Drugs will be tested simultaneously, which it's hoped will speed up the process of finding new treatments for this common ...

Safe completion of the first dose cohort in which QEL-005 was well tolerated, with no dose-limiting toxicities (DLTs), no treatment-related ...

Tuesday to advance $1 million for a new diabetes care program amid questions about the funding source and its sustainability.

Several factors have led to a pediatric endocrinologist shortage in the U.S. that has caused large care gaps for children, ...

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has reached a key milestone in its pivotal Phase 3 diabetic foot infection trial, with an independent Data Monitoring Committee (DMC) set to review ...

Weight loss also increased with the dose. Participants receiving 4 mg, 9 mg, or 12 mg of retatrutide lost an average of 11.5% ...

Al Ahli Hospital has successfully hosted its Second Diabetes and Endocrinology Conference at the Sheraton Grand Doha Resort ...

Qualified ophthalmologists can build careers in a variety of settings, including government hospitals, private hospitals, ...

Three changes show what AI is already doing to everyday care. For someone with diabetes, an automated insulin delivery system ...

Eli Lilly and Company announced that new data from across its oncology portfolio will be presented at the European Society for Medical Oncology Congress, taking place October 23?27 in Madrid, Spain.

With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.

India's diabetes treatment market is changing rapidly with new drugs and innovations such as weekly insulin, opening up new ...